3rd World Congress on Cancer Biology and Immunology 2019
NH Milano FieraRho, ITALY Visit the Venue to read more
Cancer Biology 2019 greetings you to attend the "3rd World Congress on Cancer Biology and Immunology" under the theme of "Don't count the days make the Days Count" during March 11-13, 2019 at Milan, Italy. Cancer Biology 2019 is the premier event that unites an interesting and International blend of specialists, analysts and leaders both from the academia world and industry over the globe to trade their insight, experience and research advancements to build Cancer Research researchers, industrialists and business visionaries meet.
Cancer is caused when cells inside the body accumulate genetic changes and begin to develop in an uncontrolled way. Cancer biology is understanding how cancer creates and advances, including how gene mutations drive the development and spread of cancer cells, and how tumors communicate with their encompassing condition, is crucial for the discovery of new focused on malignancy treatment.Immunology is the study of the immune system and is an important branch of the restorative and organic sciences. The immune system protects us from disease through different lines of barrier. If the immune system isn't working as it should, it can bring about sickness, for example, autoimmunity, allergy and cancer.
Importance and Scope of Cancer Biology and Immunology
Cancer is the second driving reason for death around the world. It's urgent to recall that tumor isn't one disease – it's in excess of 250 malignancy infections included. All extraordinary, remarkable diseases, which require diverse methodologies for treatment. Medicines that work for a few growths don't work for others and here and there those medications just quit working. Just overall research will improve our comprehension of growth and help us find and grow better, more successful medicines. What's more, just a worldwide look for answers will enable us to get to grasps with this sickness. The meeting will give an extraordinary open door for the agents from Universities and Institutes to connect with the world class Scientists and Industry Professionals working in the field of cancer biology. The meeting will furnish with an uncommon open door for the delegates also from Universities and Institutes to collaborate with the world class Scientists and Industry Professionals working in the field of disease/oncology.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
NH Milano Fiera
Viale degli Alberghi,
Abstract Submission for Cancer Biology 2019 will open on 18 June, 2018. Please refer to our guidelines below for more information. If you have any questions please contact the Congress or Event team on: firstname.lastname@example.org
Why submit an abstract?
To present your research and receive feedback from expertise working in the same field
To ensure your work is accessible to the international research community
To be considered for an oral presentation in dedicated proffered paper sessions and on the main programme
To expansion recognition from your nobles; all abstracts are citable and will be published on the Journal
To win prestigious research prizes and awards
Who is eligible to submit an abstract?
Any author working in cancer research, immunology or related fields who has acquired the relevant approvals.
Is there a cost to submit an abstract?
No, submitting an abstract is free of cost but presenting authors must register and attend the conference should their abstract be accepted.
Are there any limits in the number of abstracts an author can submit?
Individuals may submit up to two abstracts as the main author
Individuals may submit an unlimited number of abstracts as co-authors
What information do I need to submit my abstact?
Full contact details of the main author and title, name, surname, organisation, city, country and email address of all co-authors (omit department names, divisions, institutes, etc.)
Any disclosures including research funding and conflicts of interest of any listed authors
Confirmation that the research undertaken was approved by an appropriate ethics committee or review board and that, if appropriate, informed consent was obtained for all subjects
Permission from all co-authors to submit the abstract
Key Dates and Deadlines:
First round of abstract submission: 24 September, 2018
Earlybird registration: 1 October, 2018
Final registration: 11 March, 2019
Abstract submission deadline 2019-03-11
Exhibitors store the excessive prominence with conference participants throughout the academic and social events. Exhibits are open throughout the conference and all the speakers and delegates have access to all the booths. And, we bring the traffic to you!
Developing of e-commerce is rapid than ever leading to extensive marketing campaign uniting high quality audience who are willing to make a purchase with your organization. The conference is organised in a way to attract high grade audience who ensure to approach the conference with strong response rate.
Meet and connect with prospective customers
Strengthen your bond with existing customers
Learn about new developments in your industry
Meet new companies that can help your business
Close deals with new customers during the show
Strengthen (or establish) your brand
Learn what your competitors are doing right
Rapidly expand your database of sales leads
Speak directly to your target market
Optimise your sales and lead generation strategy
Benefits for exhibiting at Cancer Biology and Immunology 2019:
One complimentary congress registration
One Exhibit booth (Size-3X3 Sqm)
Client relationships (B2B Meeting)
One Poster presentation award on your Company's name
Brand announcing at opening and closing ceremonies
Logo recognition on congress website sponsorship page.
One insert provided by the exhibitor in the congress delegate bags
Recognition listing in the final conference program
One page advertisement in the conference Proceedings
Attendee list post conference
Video teaser played during the inaugration (Video provided by you)
+1 (563) 447-3392, +1 (563) 447-2447